Atlantic Coastal Acquisition Corp. II (ACABW) Competitors $0.04 +0.01 (+56.86%) As of 04/2/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock ACABW vs. ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Atlantic Coastal Acquisition Corp. II stock or one of its competitors? The main competitors of Atlantic Coastal Acquisition Corp. II include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Atlantic Coastal Acquisition Corp. II vs. 180 Life Sciences 4D pharma Aardvark Therapeutics Aesther Healthcare Acquisition Ainos Alvotech Biofrontera biote BriaCell Therapeutics Celularity 180 Life Sciences (NASDAQ:ATNFW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, community ranking, institutional ownership, dividends, risk, profitability, media sentiment and valuation. Does the MarketBeat Community believe in ATNFW or ACABW? 180 Life Sciences and Atlantic Coastal Acquisition Corp. II both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/AAtlantic Coastal Acquisition Corp. IIN/AN/A Is ATNFW or ACABW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A Does the media refer more to ATNFW or ACABW? In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score. Company Overall Sentiment 180 Life Sciences Neutral Atlantic Coastal Acquisition Corp. II Neutral Which has better earnings & valuation, ATNFW or ACABW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AAtlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A Summary180 Life Sciences and Atlantic Coastal Acquisition Corp. II tied by winning 0 of the 0 factors compared between the two stocks. Remove Ads Get Atlantic Coastal Acquisition Corp. II News Delivered to You Automatically Sign up to receive the latest news and ratings for ACABW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACABW vs. The Competition Export to ExcelMetricAtlantic Coastal Acquisition Corp. IIShell Companies IndustryFinancial SectorNASDAQ ExchangeMarket CapN/A$28.92M$4.13B$7.57BDividend YieldN/A5.35%4.14%4.04%P/E RatioN/A0.5115.9218.16Price / SalesN/A454.971,616.5586.29Price / CashN/A178.7348.9734.64Price / BookN/A92.073.334.01Net IncomeN/A-$141.08M$1.28B$247.18M7 Day PerformanceN/A0.40%-1.57%-5.86%1 Month PerformanceN/A0.37%-2.10%-6.95%1 Year PerformanceN/A3.68%8.97%-3.71% Atlantic Coastal Acquisition Corp. II Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACABWAtlantic Coastal Acquisition Corp. IIN/A$0.04+56.9%N/AN/A$0.00N/A0.0015ATNFW180 Life SciencesN/A$0.01flatN/A-41.7%$0.00N/A0.007LBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAARDAardvark TherapeuticsN/A$9.09-1.6%$30.50+235.5%N/A$0.00N/A0.0018Analyst ForecastNews CoverageGap DownAEHAWAesther Healthcare AcquisitionN/A$0.02+11.8%N/A-92.5%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.11-34.3%N/A+71.1%$0.00$20,729.000.0040Positive NewsGap DownALVOWAlvotechN/A$2.36-9.6%N/A-53.3%$0.00$391.87M0.004Positive NewsGap DownBFRIWBiofronteraN/A$0.09flatN/A+20.4%$0.00$35.36M0.0070Positive NewsGap DownBTMDWbioteN/A$0.07flatN/A-88.4%$0.00$197.19M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.10-7.1%N/A-91.6%$0.00N/A0.008CELUWCelularityN/A$0.05+25.0%N/A-13.8%$0.00$48.20M0.00220Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aardvark Therapeutics Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Celularity Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACABW) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atlantic Coastal Acquisition Corp. II Please log in to your account or sign up in order to add this asset to your watchlist. Share Atlantic Coastal Acquisition Corp. II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACABW Stock Free ACABW Stock Alerts